Sensitivity and specificity of some methods used in diagnosis of invasive candidiasis as compared to conventional methods.
Abstract
The burden of Candidiasis continues to increase and so does the Candida species. Although Candida species are closely similar phenotypically, they differ from each other in terms of epidemiology, genetic characteristics, antifungal susceptibility and virulence profile. Therefore, reliable and accurate laboratory methods for identification of Candida species can determine the Candidiasis burden and enable the administration of the most appropriate antifungal drug therapy to reduce fungal mortality rates. Conventional and biochemical methods are often used in identification of Candida species. However, these techniques are specific and sensitive enough in detecting the non albicans candida (NAC) species. Molecular techniques have improved the laboratory diagnosis and management of Candidiasis due to improved sensitivity and specificity threshold. This chapter provides an overview of different laboratory methods for diagnosis of Candidiasis.
Keywords
- Candida
- identification
- candidiasis
- laboratory
- diagnosis
- non-C. albicans
1. Introduction
There is a global raise in the burden of Candidiasis among immunocompromised individuals and this has to an increase in
The phenotypic appearance of
2. Laboratory diagnosis of candidiasis
The laboratory diagnosis of the Candidiasis involves the use of both Conventional (phenotypic) and molecular (genotypic) methods to detect visible and genetic characteristics of Candida respectively.
2.1 Conventional methods
Conventional methods are still commonly used for diagnosis and identification of fungi. These techniques are based on microscopic examination and fungal culture. Oral swab is collected, followed by microscopy and culture on selective media [4]. Microscopy can be done directly either from fresh samples or from fungal cultures. However, microscopy is non-specific, as different species can show the same morphological patterns and it is not possible to identify the
Indirect nonculture-based methods are available such as
Enzyme-linked immunosorbent assay (ELISA) kits can be used to identify both mannan and anti-mannan antibodies however, this test is not recommended for identification of
2.2 Molecular method
Molecular methods are more accurate and rapid in detecting
Molecular techniques are categorized into two methods, i.e., polymerase chain reaction-based methods and non-polymerase chain reaction (PCR) based methods.
2.2.1 Polymerase chain reaction-based techniques
Polymerase chain reaction (PCR) is one of the most important molecular techniques used to detect
2.2.1.1 Polymerase chain reaction (PCR)
PCR is based on the amplification of a small specific DNA target through multiple repeated cycles of temperature changes into multiple copies. The main PCR steps are denaturation of the template DNA into single strands (94–98°C), annealing of the primers to the target sequence (50–65°C), and elongation whereby DNA polymerase elongates a DNA complementary to each strand of the target (72°C) [27].
Various PCR techniques have been developed, such as real-time PCR, Restriction Fragment Length Polymorphism (RFLP) PCR technique, multiplex PCR, reverse transcriptase PCR and nested PCR [27, 28].
Real-time PCR can be used to quantify the PCR product during amplification. Moreover, it has advantages over the conventional PCR in that it does not require agarose gel electrophoresis to visualize the amplified products. In real-time PCR, the amplified product can be measured automatically after each cycle by a fluorometer [29].
Nested PCR is based on the amplification of DNA by using two sets of primers to improve its specificity and sensitivity.
Restriction Fragment Length Polymorphism (RFLP) PCR is an important technique to detect and identify strains of
Multiplex PCR requires multiple different primers and specific probes labeled with different fluorophores in a single PCR tube to allow the identification of many different
2.2.1.2 Sequencing
Sanger sequencing is a first-generation sequencing technique developed by Sanger Frederick and it is based on chain-termination (Sanger
Next generation sequencing (NGS) is accurate and rapid high throughput sequencing technique and is very vital in genome sequencing, fungal research, diagnostic purposes, outbreak monitoring [36]. Most of NGS platforms including the Ion Torrent PGM (Life Technologies), HiSeq, MiSeq and NextSeq (Illumina), 454 GS (Roche) and SOLiD System (Applied Biosystems) are based on sequencing by synthesis and have three main steps: template preparation, sequencing and imaging and data analysis [37, 38]. In addition to
Pyrosequencing is another PCR based technique which depends on the release of pyrophosphate when nucleotides are incorporated into the nucleic acid chain by DNA polymerase and produced pyrophosphate is then subsequently converted to Adenosine-5’triphosphate (ATP) by ATP sulfurylase, and that provides energy for luciferin oxidation by luciferase, which produces light that can be detected as a peak on the pyrogram [37]. Any unincorporated nucleotides are degraded by apyrase to allow iterative nucleotide addition into the nucleic acid chain and peak heights are associated with the number of the same nucleotides added to the nascent strand [41].
Pyrosequencing is a rapid and accurate molecular method for the detection of point mutations in any selected gene within short DNA fragments. It has been used widely for the identification and detection of antifungal drug resistance [42].
2.2.2 Non-polymerase chain reaction-based methods
These methods can facilitate rapid identification of
MALDI-TOF MS is a method that uses mass spectrometry to identify the protein fingerprints of microorganisms that are compared with databases of reference spectra [43]. MALDI-TOF MS is able to accurately detect and identify
2.2.3 The internal transcribed spacer marker for Candida species identification and phylogenetics
The ITS region of ribosomal DNA (rDNA) is the most useful genetic marker for rapid and accurate molecular identification of
3. Conclusions
Emergence of non albicans
References
- 1.
Yulianto M, Hidayati AN, Ervianti E. Association between etiologic species with CD4 count and clinical features of oral candidiasis among HIV/AIDS patients. Journal of the Egyptian Womem’s Dermatologic Society. 2022; 19 :51-57. DOI: 10.4103/jewd.jewd - 2.
Mushi MF, Bader O, Taverne-Ghadwal L, Bii C, Groß U, Mshana SE. Oral candidiasis among African human immunodeficiency virus-infected individuals: 10 years of systematic review and meta-analysis from sub-Saharan Africa. Journal of Oral Microbiology. 2017; 9 (1):1-10. DOI: 10.1080/20002297.2017.1317579 - 3.
Id KS et al. Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing. PLoS One. 2019; 14 (1):1-19 - 4.
Mastammanavar D, Hunasgi S, Koneru A, Vanishree M, Surekha R, Vardendra M. Techniques used for isolation and identification of Candida from the oral cavity. Ann. Essences Dent. 2014; 6 (1):44. DOI: 10.5958/0976-156x.2014.00013.6 - 5.
Taverne-Ghadwal L et al. Epidemiology and prevalence of Oral candidiasis in HIV patients from Chad in the post-HAART era. Frontiers in Microbiology. 2022; 13 (February):1-12. DOI: 10.3389/fmicb.2022.844069 - 6.
Mushi MF et al. Oral candidiasis among African human immunodeficiency virus-infected individuals: 10 years of systematic review and meta-analysis from sub-Saharan Africa. Journal of Oral Microbiology. 2017; 9 (1):1317579. DOI: 10.1080/20002297.2017.1317579 - 7.
Fatima A, Bashir G, Wani T, Jan A, Kohli A, Khan MS. Molecular identification of Candida species isolated from cases of neonatal candidemia using polymerase chain reaction-restriction fragment length polymorphism in a tertiary care hospital. Indian Journal of Pathology & Microbiology. 2017; 60 (1):61-65. DOI: 10.4103/0377-4929.200023 - 8.
Deorukhkar, Roushani S. Identification of Candida species: Conventional methods in the era of molecular diagnosis. Ann. Microbiol. Immunol. 2018; 1 (1):1002 - 9.
Cuenca-Estrella M, Bassetti M, Lass-Flörl C, Ráčil Z, Richardson M, Rogers TR. Detection and investigation of invasive mould disease. The Journal of Antimicrobial Chemotherapy. 2011; 66 (SUPPL. 1):15-24. DOI: 10.1093/jac/dkq438 - 10.
Pincus DH, Orenga S, Chatellier S. Yeast identification - past, present, and future methods. Medical Mycology. 2007; 45 (2):97-121. DOI: 10.1080/13693780601059936 - 11.
Phoompoung P, Chayakulkeeree M. Recent Progress in the diagnosis of pathogenic Candida species in blood culture. Mycopathologia. 2016; 181 (5-6):363-369. DOI: 10.1007/s11046-016-0003-x - 12.
Neppelenbroek KH et al. Identification of Candida species in the clinical laboratory: A review of conventional, commercial, and molecular techniques. Oral Diseases. 2014; 20 (4):329-344. DOI: 10.1111/odi.12123 - 13.
Sahand IH, Moragues MD, Robert R, Quindós G, Pontón J. Evaluation of Bichro-Dubli Fumouze® to distinguish Candida dubliniensis from Candida albicans. Diagnostic Microbiology and Infectious Disease. 2006; 55 (2):165-167. DOI: 10.1016/j.diagmicrobio.2005.12.007 - 14.
Criseo G, Scordino F, Romeo O. Current methods for identifying clinically important cryptic Candida species. Journal of Microbiological Methods. 2015; 111 :50-56. DOI: 10.1016/j.mimet.2015.02.004 - 15.
Grisolia A. Molecular methods developed for the identification and characterization of Candida species. Int. J. Genet. Sci. 2017; 4 (1):1-6. DOI: 10.15226/2377-4274/4/1/00114 - 16.
Pfaller MA, Castanheira M. Nosocomial candidiasis: Antifungal stewardship and the importance of rapid diagnosis. Medical Mycology. 2016; 54 (1):1-22. DOI: 10.1093/mmy/myv076 - 17.
Fuchs S, Lass-flörl C. Diagnostic performance of a novel multiplex PCR assay for Candidemia among ICU patients. J Fungi. 2019; 5 (3):86 - 18.
Calandra T, Sanguinetti M, Poulain D, Viscoli C. The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: Recommendations from the third European conference on infections in leukemia. Critical Care. 2010; 14 :1-14 - 19.
Clancy CJ, Hong M. Diagnosing Invasive Candidiasis. Journal of Clinical Microbiology. 2018; 56, 5 :e01909-e01901 - 20.
Carmen ZB, Me C, Parra-sa M, Leo C, Martı E. Candida albicans germ-tube antibody: Evaluation of a new automatic assay for diagnosing invasive candidiasis in ICU patients. Mycopathologia. 2017; 182 (7-8):645-652. DOI: 10.1007/s11046-017-0125-9 - 21.
Abdelhamed AM et al. Multicenter evaluation of Candida QuickFISH BC for identification of Candida species directly from blood culture bottles. Journal of Clinical Microbiology. 2015; 53 (5):1672-1676. DOI: 10.1128/JCM.00549-15 - 22.
Shamim M, Kumar P, Kumar RR, Kumar M, Kumar RR, Singh KN. Assessing fungal biodiversity using molecular markers. In: Singh BP, Gupta VK, editors. Molecular Markers in Mycology. Fungal Biology. Cham: Springer; 2017 - 23.
Schelenz S et al. British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases. The Lancet Infectious Diseases. 2015; 15 (4):461-474. DOI: 10.1016/S1473-3099(15)70006-X - 24.
Ahmad S, Khan Z. Invasive candidiasis: A review of nonculture-based laboratory diagnostic methods. Indian Journal of Medical Microbiology. 2012; 30 :264-270. DOI: 10.4103/0255-0857.99482 - 25.
Chen YC et al. Identification of medically important yeasts using PCR-based detection of DNA sequence polymorphisms in the internal transcribed spacer 2 region of the rRNA genes. Journal of Clinical Microbiology. 2000; 38 (6):2302-2310 - 26.
Padovan ACB, Melo AS d A, Colombo AL. Systematic review and new insights into the molecular characterization of the Candida rugosa species complex. Fungal Genetics and Biology. 2013; 61 :33-41. DOI: 10.1016/j.fgb.2013.10.007 - 27.
Asadzadeh M, Ahmad S, Al-Sweih N, Khan Z. Rapid and accurate identification of candida albicans and candida dubliniensis by real-time PCR and melting curve analysis. Medical Principles and Practice. 2019; 27 (6):543-548. DOI: 10.1159/000493426 - 28.
Arvanitis M, Anagnostou T, Burgwyn B, Caliendo AM, Mylonakis E. Molecular and nonmolecular diagnostic methods for invasive fungal. Clinical Microbiology Reviews. 2014; 27 (3):490-526. DOI: 10.1128/CMR.00091-13 - 29.
Fricke S et al. A real-time PCR assay for the differentiation of Candida species. Journal of Applied Microbiology. 2010; 109 (4):1150-1158. DOI: 10.1111/j.1365-2672.2010.04736.x - 30.
Kanbe T, Horii T, Arishima T, Ozeki M, Kikuchi A. PCR-based identification of pathogenic Candida species using primer mixes specific to Candida DNA topoisomerase II genes. Yeast. 2002; 19 :973-989. DOI: 10.1002/yea.892 - 31.
Luo G, Samaranayake LP, Cheung BPK, Tang G. Reverse transcriptase polymerase chain reaction (RT-PCR) detection of HLP gene expression in Candida glabrata and its possible role in in vitro haemolysin production. APMIS. 2004; 112 :283-290 - 32.
McManus BA, Coleman DC. Molecular epidemiology, phylogeny and evolution of Candida albicans. Infection, Genetics and Evolution. 2014; 21 :166-178. DOI: 10.1016/j.meegid.2013.11.008 - 33.
Carvalho A, Martins ML, Rodrigues AG, Ludovico P. Multiplex PCR identification of eight clinically relevant Candida species. Medical Mycology. 2007; 45 (7):619-627. DOI: 10.1080/13693780701501787 - 34.
Carvalho A et al. Multiplex PCR identification of eight clinically relevant Candida species. Medical Mycology. 2007; 45 (7):619-627. DOI: 10.1080/13693780701501787 - 35.
Allison LA. Fundamental Molecular Biology. Malden, MA, USA: Black Well Publishing, Oxford; 2007 - 36.
El-kamand S, Papanicolaou A, Morton CO, Morton CO. The use of whole genome and next-generation sequencing in the diagnosis of invasive fungal disease. Current Fungal Infection Reports. 2019; 13 :284-291 - 37.
Diabetes J, Khan MA, Khan ST, Tripathi V, Kumar P. Microbial Genomics in Sustainable Agroecosystems. Midtown Manhattan, New York: Springer Nature; 2019. DOI: 10.1007/978-981-32-9860-6 - 38.
Liu L et al. Comparison of next-generation sequencing systems. Journal of Biomedicine & Biotechnology. 2012; 2012 :251364. DOI: 10.1155/2012/251364 - 39.
Jain M, Olsen HE, Paten B, Akeson M. The Oxford Nanopore MinION: Delivery of nanopore sequencing to the genomics community. Genome Biology. 2016; 17 (1):1-11. DOI: 10.1186/s13059-016-1103-0 - 40.
Kono N, Arakawa K. Nanopore sequencing: Review of potential applications in functional genomics. Development, Growth & Differentiation. 2019; 61 (5):316-326. DOI: 10.1111/dgd.12608 - 41.
Chowdhury A, Mannan SBIN, Mazumdar RM. Pyrosequencing-principles and applications. International Journal of Life Science and Pharma Research. 2012; 2 (2):65-76 - 42.
van der Torre MH, Novak-frazer L, Rautemaa-richardson R. Detecting azole-antifungal resistance in aspergillus fumigatus by pyrosequencing. J. Fungi. 2020; 6 (1):1-15. DOI: 10.3390/jof6010012 - 43.
Posteraro B, Vella A, De Carolis E, Sanguinetti M. Molecular detection of resistance to azole components. Methods in Molecular Biology. 2017; 1508 :423-435. DOI: 10.1007/978-1-4939-6515-1_24 - 44.
Rychert J. Benefits and limitations of MALDI-TOF mass spectrometry for the identification of microorganisms. The Journal of Infection. 2019; 2 (4):1-5. DOI: 10.29245/2689-9981/2019/4.1142 - 45.
Diba K, Makhdoomi K, Aboutalebian S. Molecular identification and antifungal susceptibility profiles of non- albicans Candida species clinical isolates. Microbiology & Infectious Diseases. 2020; 1 :66-72 - 46.
Wen X, Chen Q , Yin H, Wu S, Wang X. Rapid identi fi cation of clinical common invasive fungi via a multi-channel real-time fl uorescent polymerase chain reaction melting curve analysis. Medicine. 2020; 99 (7):e19194 - 47.
Yiş R, Doluca M. Identification of candida species by restriction enzyme analysis. Turkish J. Med. Sci. 2018; 48 (5):1058-1067. DOI: 10.3906/sag-1802-11 - 48.
Yahaya Hassan SAA, Aminu I. Candida diagnostic platforms: Essential In early management of Candida infections. Fudma Journal of Sciences. 2021; 5 (2):59-71 - 49.
Lõoke M, Kristjuhan K, Kristjuhan A. Extraction of genomic DNA from yeasts for PCR-based applications. BioTechniques. 2017; 62 (1):v. DOI: 10.2144/000114497